ZA200404172B - Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith. - Google Patents

Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith.

Info

Publication number
ZA200404172B
ZA200404172B ZA200404172A ZA200404172A ZA200404172B ZA 200404172 B ZA200404172 B ZA 200404172B ZA 200404172 A ZA200404172 A ZA 200404172A ZA 200404172 A ZA200404172 A ZA 200404172A ZA 200404172 B ZA200404172 B ZA 200404172B
Authority
ZA
South Africa
Prior art keywords
treatment
refreshedness
grogginess
waking
therewith
Prior art date
Application number
ZA200404172A
Other languages
English (en)
Inventor
Paliniswamy Sunderraj
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of ZA200404172B publication Critical patent/ZA200404172B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
ZA200404172A 2001-11-30 2004-05-27 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith. ZA200404172B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0128674.9A GB0128674D0 (en) 2001-11-30 2001-11-30 Treatment of sleep disorders and the like

Publications (1)

Publication Number Publication Date
ZA200404172B true ZA200404172B (en) 2005-09-01

Family

ID=9926729

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200404172A ZA200404172B (en) 2001-11-30 2004-05-27 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith.

Country Status (13)

Country Link
US (4) US20030134878A1 (xx)
EP (1) EP1455786A1 (xx)
JP (1) JP2005515200A (xx)
CN (1) CN1617723A (xx)
AU (2) AU2002350897B2 (xx)
CA (1) CA2468044A1 (xx)
GB (3) GB0128674D0 (xx)
IL (1) IL162146A0 (xx)
NO (1) NO20042389L (xx)
PL (1) PL370258A1 (xx)
RU (1) RU2320340C2 (xx)
WO (1) WO2003047580A1 (xx)
ZA (1) ZA200404172B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0312425D0 (en) * 2003-05-30 2003-07-09 Boots Co Plc Use of a compound in the treatment of sleep disorders and the like,in providing refreshedness on waking and a method for the treatment of grogginess therewith
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
DE602004023861D1 (de) * 2003-09-03 2009-12-10 Novartis Ag Verwendung von oxcarbazepin zur verbesserung des schlafes bei patienten die an chronischem schmerz leiden
KR100870381B1 (ko) 2004-10-14 2008-11-25 다이킨 고교 가부시키가이샤 분위기개변방법, 그리고 이에 이용되는 분무제 및 분무장치
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
US20070166336A1 (en) * 2005-12-13 2007-07-19 David Delmarre Stable and palatable oral liquid sumatriptan compositions
US20070299127A1 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
CN101868253A (zh) * 2007-11-21 2010-10-20 宝洁公司 可用于咳嗽治疗的制剂、方法和试剂盒
WO2011035120A2 (en) * 2009-09-17 2011-03-24 Gk Ventures, L.L.C. Therapeutic composition to treat lesions caused by herpes simplex virus
NZ735777A (en) 2015-03-26 2023-03-31 Jacqueline M Iversen Methods and compositions to inhibit symptoms associated with veisalgia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269835A (en) * 1979-12-13 1981-05-26 Whittle Barry J Nasal composition for relieving nasal distress
US4639459A (en) * 1983-02-01 1987-01-27 Burroughs Wellcome Co. Use of trifluoromethyl compounds
US4642231A (en) * 1983-07-20 1987-02-10 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
JP2003506484A (ja) * 1999-08-13 2003-02-18 ベラ・ファーマシューティカルズ・インコーポレイテッド 非常に低用量のシクロベンザプリンを使用する睡眠障害の処置または予防するための組成物使用
CN1499960A (zh) * 2001-03-13 2004-05-26 ����˹��ҩ�﹫˾ 时间治疗剂型
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines

Also Published As

Publication number Publication date
GB0227708D0 (en) 2003-01-08
CN1617723A (zh) 2005-05-18
US20050282869A1 (en) 2005-12-22
AU2002350897A1 (en) 2003-06-17
CA2468044A1 (en) 2003-06-12
GB0228045D0 (en) 2003-01-08
JP2005515200A (ja) 2005-05-26
EP1455786A1 (en) 2004-09-15
US20070015800A1 (en) 2007-01-18
PL370258A1 (en) 2005-05-16
RU2320340C2 (ru) 2008-03-27
GB2383537B (en) 2003-12-10
WO2003047580A1 (en) 2003-06-12
NO20042389L (no) 2004-06-08
US20030134878A1 (en) 2003-07-17
GB0128674D0 (en) 2002-01-23
AU2002350897B2 (en) 2008-12-11
RU2004119832A (ru) 2005-04-20
AU2002313364B2 (en) 2004-02-19
GB2383537A (en) 2003-07-02
US20040029927A1 (en) 2004-02-12
IL162146A0 (en) 2005-11-20

Similar Documents

Publication Publication Date Title
GB0312419D0 (en) Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
MXPA03007960A (es) Compuestos y metodos para el tratamiento de desordenes urogenitales.
EG25097A (en) Piprazinyl and diazapanyl benzamides and benzthioamides.
HUP0401279A3 (en) Polyurethane elastomers, method for the production thereof and their use
EP1426334A4 (en) ACTIVE CHARCOAL, PROCESS FOR THE PRODUCTION AND USE THEREOF
ZA200202542B (en) Treating sleep disorders using desloratadine.
ZA200306171B (en) (Diazolo-pyridinyl)-pyrimidines for use in treatment of CNS disorders and diabetes.
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
ZA200404172B (en) Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith.
AU2002313364A1 (en) Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
ZA200205098B (en) Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders.
ZA200407361B (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof.
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU2003302915A1 (en) Waste-water filter, waste-water treatment device and method incorporating the waste-water filter
GB0312425D0 (en) Use of a compound in the treatment of sleep disorders and the like,in providing refreshedness on waking and a method for the treatment of grogginess therewith
IL156162A0 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof.
HK1043921A1 (en) Ornamental pad and method for producing the same.
HUP0300306A3 (en) Cyclipostins, a method for their production and the use of the same
GB0312792D0 (en) Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
ZA200204018B (en) Combination treatment for depression and anxiety.
MXPA03007550A (es) Derivados coloporosidos, proceso para su preparacion y su uso.
GB0312793D0 (en) Use of a compound in the treatment of sleep disorders and the like in providing refreshedness on waking and a method for the treatment of grogginess therewith
MXPA03004632A (es) Klainetina y sus derivados, metodo para su produccion y su uso.
AU2002256705A1 (en) Corrosion-stable laminate, method for the production thereof, and its use